Trial intelligence / Profile preview

Naproxen Sodium and Diphenhydramine for Postsurgical Dental Pain and Sleep

NCT01495858Phase 3Completed

Sponsor
Bayer
Start
Dec 2011
Primary completion
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Aprol and diphenhydramine in postoperative pain and insomnia disorder, sponsored by Bayer. Started Dec 2011; status: completed.

02

Drugs

Aproldiphenhydramine
03

Conditions

postoperative paininsomnia disorder

Beyond the preview

Go deeper on NCT01495858.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01495858.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call